How sponsors can accelerate contracting and budget negotiations
Instead of approaching every study as a new negotiation, sponsors can use technology to leverage what they’ve previously learned about sites and work more efficiently.
Comment & Opinion
ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide
IDWeek 2026: BNT163 poised to fulfil a substantial unmet need for genital herpes
ESMO26: Intismeran sets new benchmark in adjuvant melanoma
IDWeek 2026: meropenem-pilabactam successfully targets critical priority pathogens
ESMO26: Promising results seen for opamtistomig in advanced heavily treated epNEC
ESMO26: Sac-TMT’s OptiTROP-Lung04 survival gain holds, putting the onus on MSD
IDWeek 2026: novel antifungal turletricin demonstrates positive Phase II results
